Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
9
NMPA:9
Drug Approvals
Oseltamivir Phosphate for Suspension
- Product Name
- 磷酸奥司他韦干混悬剂
- Approval Number
- 国药准字H20253829
- Approval Date
- Apr 8, 2025
NMPA
Potassium Chloride Oral Solution
- Product Name
- 氯化钾口服溶液
- Approval Number
- 国药准字H20244120
- Approval Date
- Jun 25, 2024
NMPA
Levosalbutamol Hydrochloride Nebuliser Solution
- Product Name
- 盐酸左沙丁胺醇雾化吸入溶液
- Approval Number
- 国药准字H20243992
- Approval Date
- Jun 11, 2024
NMPA
Levosalbutamol Hydrochloride Nebuliser Solution
- Product Name
- 盐酸左沙丁胺醇雾化吸入溶液
- Approval Number
- 国药准字H20243993
- Approval Date
- Jun 11, 2024
NMPA
Bepotastine Besilate Orally Disintegrating Tablets
- Product Name
- 苯磺贝他斯汀口崩片
- Approval Number
- 国药准字H20233733
- Approval Date
- Jun 14, 2023
NMPA
Tofacitinib Citrate Tablets
- Product Name
- 枸橼酸托法替布片
- Approval Number
- 国药准字H20223887
- Approval Date
- Nov 30, 2022
NMPA
Bepotastine Besilate Tablets
- Product Name
- 苯磺贝他斯汀片
- Approval Number
- 国药准字H20213162
- Approval Date
- Mar 9, 2021
NMPA
Clinical Trials
No trials found
News
No news found